We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
Cap. Flow
+$1.75B
Cap. Flow %
4%
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$674M
2
IBM icon
IBM
IBM
+$408M
3
TD icon
Toronto Dominion Bank
TD
+$392M
4
BIIB icon
Biogen
BIIB
+$340M
5
BA icon
Boeing
BA
+$319M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$366M
2
CVS icon
CVS Health
CVS
+$350M
3
WBA
Walgreens Boots Alliance
WBA
+$333M
4
TSM icon
TSMC
TSM
+$323M
5
MRK icon
Merck
MRK
+$283M

Sector Composition

Rank Sector Weight
1 Technology 17.47%
2 Healthcare 17.17%
3 Financials 16.49%
4 Consumer Discretionary 12.16%
5 Industrials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETFC
1426
DELISTED
E*Trade Financial Corporation
ETFC
-5,600
Closed -$278K
DLPH
1427
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
-155,056
Closed -$8.14M
CCMP
1428
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-22,697
Closed -$2.13M
GCAP
1429
DELISTED
Gain Capital Holdings, Inc.
GCAP
-104,782
Closed -$1.05M
LM
1430
DELISTED
Legg Mason, Inc.
LM
-184,954
Closed -$7.76M
FNJN
1431
DELISTED
Finjan Holdings, Inc.
FNJN
-75,267
Closed -$163K
GNC
1432
DELISTED
GNC Holdings, Inc.
GNC
-119,200
Closed -$440K
AGN
1433
DELISTED
Allergan plc
AGN
-163,000
Closed -$26.7M
CYOU
1434
DELISTED
Changyou.com Limited American Depositary Share
CYOU
-148,215
Closed -$5.4M
AYR
1435
DELISTED
Aircastle Ltd
AYR
-226,751
Closed -$5.3M
INXN
1436
DELISTED
Interxion Holding N.V.
INXN
-10,000
Closed -$589K
DPLO
1437
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-21,100
Closed -$423K
IPHS
1438
DELISTED
Innophos Holdings, Inc.
IPHS
-93,060
Closed -$4.35M
LPT
1439
DELISTED
Liberty Property Trust
LPT
-19,400
Closed -$834K
FGP
1440
DELISTED
Ferrellgas Partners, L.P.
FGP
-18,000
Closed -$77K
OLBK
1441
DELISTED
Old Line Bancshares, Inc.
OLBK
-14,920
Closed -$439K
RTEC
1442
DELISTED
Rudolph Technologies Inc
RTEC
-115,353
Closed -$2.76M
BID
1443
DELISTED
Sotheby's
BID
-44,700
Closed -$2.31M
OAK
1444
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
-27,500
Closed -$1.16M
WP
1445
DELISTED
Worldpay, Inc.
WP
-24,966
Closed -$1.84M
HIFR
1446
DELISTED
InfraREIT, Inc.
HIFR
-181,017
Closed -$3.36M
ORM
1447
DELISTED
Owens Realty Mortgage, Inc.
ORM
-14,523
Closed -$233K
ICON
1448
DELISTED
Iconix Brand Group, Inc.
ICON
-38,369
Closed -$495K
NXEO
1449
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
-77,100
Closed -$702K
WRD
1450
DELISTED
WildHorse Resource Development
WRD
-73,601
Closed -$1.35M

Similar funds

Arrowstreet Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.

  • Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
  • Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
  • Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
  • Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
  • Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
  • Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
  • Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.

Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.